| Application no. and date | 02756952.4 (espacenet) (Federated) (European Patent Register), 20020805 | | Patent/reg. no. and date | DK/EP 1414409, 20070214 | | Publication date | 20040506 | | Priority no. and date | US 310372 P, 20010806 | | EP pub. no. and date |
EP 1414409 20040506 | | Effective date | | | Applicant/owner | Pharmacia Corporation, 100 Route 206 North
Peapack, NJ 07977, US | | Applicant ref. no. | P42213DK01 | | Inventor | LU, Guang, Wei, 3172 Birchwood Court
Ann Arbor, MI 48105, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61K 31/635 (2006.01) , A61K 9/10 (2006.01) | | Title | Stabiliseret oral suspensionsformulering | | Int. application no. | US2002024746 | | Int. publication no. | WO2003013473 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
